National Institute on Drug Abuse (NIDA)
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$1.9M
Focus Areas
5
Top Stage
Phase 2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Ensysce Biosciences | $1.9M |
| Advanced Brain Monitoring | — |